Elevance Health, Inc. (ELV) Financial Statements
Elevance Health, Inc. (ELV) reported trailing twelve-month revenue of $201.8B (up 3.6% year on year) and net income of $5.1B as of 2026-09-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $6.5B.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
ELVElevance Health, Inc.Follow ELV — free
—
Price chart with a free account
- Market cap
- 95.1B
- P/E TTM
- 18.7
- Dividend yield
- 1.6%
- 52-week
- —
- Next earnings
- 26 Jan, in 94 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Sep 26.
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 64.94 | 58.70 | 60.71 | 61.50 | 71.02 | 73.87 | 79.16 | 84.86 | 90.04 | 92.11 | 104.21 | 121.87 | 138.64 | 156.60 | 171.34 | 177.01 | 199.13 | 201.83 | |
| Gross profit | 64.52 | 58.70 | 60.71 | 61.36 | — | — | — | — | — | — | 102.22 | 112.91 | 127.74 | 143.56 | 154.05 | 157.26 | 177.95 | 179.71 | |
| Operating income | — | 4.08 | 3.78 | 3.62 | 4.00 | 4.42 | 4.75 | 4.80 | 4.18 | 5.43 | 6.00 | 6.36 | 7.56 | 8.28 | 8.50 | 7.86 | 7.20 | 5.43 | |
| Pre-tax income | 7.40 | 4.35 | 3.96 | 3.86 | 3.84 | 4.37 | 4.63 | 4.56 | 3.96 | 5.07 | 5.99 | 6.24 | 8.00 | 7.60 | 7.72 | 7.90 | 6.71 | 6.25 | |
| Income tax | 2.66 | 1.47 | 1.31 | 1.21 | 1.21 | 1.81 | 2.07 | 2.09 | 0.12 | 1.32 | 1.18 | 1.67 | 1.85 | 1.71 | 1.72 | 1.93 | 1.05 | 1.15 | |
| Net income | 4.75 | 2.89 | 2.65 | 2.66 | 2.49 | 2.57 | 2.56 | 2.47 | 3.84 | 3.75 | 4.81 | 4.57 | 6.16 | 5.89 | 5.99 | 5.98 | 5.66 | 5.14 | |
| Diluted EPS ($) | 9.88 | 6.94 | 7.25 | 8.18 | 8.20 | 8.99 | 9.38 | 9.21 | 14.35 | 14.19 | 18.47 | 17.98 | 24.95 | 24.28 | 25.22 | 25.68 | 25.21 | 23.52 | |
| Diluted shares (bn) | — | 0.416 | 0.365 | 0.325 | 0.304 | 0.286 | 0.273 | 0.268 | 0.268 | 0.264 | 0.260 | 0.254 | 0.247 | 0.243 | 0.237 | 0.233 | 0.225 | — |
USD billions · SEC XBRL
Elevance Health, Inc. — questions
- What is Elevance Health, Inc.'s revenue?
- $201.8B over the twelve months to 2026-09-30, up 3.6% year on year, from its 10-Q and 10-K filings.
- What is Elevance Health, Inc.'s net income?
- $5.1B over the twelve months to 2026-09-30.
- What is Elevance Health, Inc.'s free cash flow?
- $6.5B over the twelve months to 2026-09-30.
- What are Elevance Health, Inc.'s diluted earnings per share?
- $23.52 over the twelve months to 2026-09-30.
Every figure on this page comes from Elevance Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.